Intranasal covid-19 vaccine protected, immunogenic: Bharat Biotech

NEW DELHI: Bharat Biotech Global Ltd. on Monday stated its intra-nasal covid-19 vaccine, BBV154, is protected, well-tolerated, and immunogenic in topics studied throughout section 3 scientific trials for number one dose and a heterologous booster dose. The corporate stated knowledge from section 3 trials were submitted for approval to nationwide regulatory government. BBV154 is a … Read more